<?xml version="1.0" encoding="UTF-8"?>
<p id="JVEv5-para-0146">Turning the focus to HBV, Dr Mala Maini (University College London, London, UK) gave an up-to-date, detailed overview of why and how an immunotherapeutic approach towards a functional cure for chronic hepatitis B (CHB) should and could be tackled.</p>
